Japan Tissue Engineering Co., Ltd. (TYO:7774)
Japan · Delayed Price · Currency is JPY 693.00
-56.00 (-7.48%)
Mar 27, 2026, 3:30 PM JST
Japan Tissue Engineering Market Cap
Japan Tissue Engineering has a market cap or net worth of 28.14 billion as of March 27, 2026. Its market cap has increased by 39.72% in one year.
Market Cap
28.14B
Enterprise Value
24.81B
Revenue
2.26B
Ranking
n/a
PE Ratio
n/a
Stock Price
693.00
Market Cap Chart
Since December 21, 2007, Japan Tissue Engineering's market cap has increased from 5.99B to 28.14B, an increase of 369.64%. That is a compound annual growth rate of 8.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 28.14B | 11.41% |
| Dec 30, 2025 | 25.26B | 34.34% |
| Dec 30, 2024 | 18.80B | -8.50% |
| Dec 29, 2023 | 20.55B | 8.35% |
| Dec 30, 2022 | 18.96B | -17.49% |
| Dec 30, 2021 | 22.99B | -8.12% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cuorips | 58.59B |
| Healios K.K. | 51.03B |
| Stella Pharma | 29.98B |
| AnGes | 23.74B |
| Renascience | 23.31B |
| RaQualia Pharma | 21.57B |
| StemRIM | 18.99B |
| ReproCELL | 17.33B |